This study is in progress, not accepting new patients
Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Disc Medicine, Inc
- ID
- NCT05308472
- Phase
- Phase 2 Erythropoietic Protoporphyria Research Study
- Study Type
- Interventional
- Participants
- About 75 people participating
- Last Updated